NEXGARD COMBO DIN 02511231
Health Canada record
| Active ingredient(s) | ESAFOXOLANER 1.2 %; EPRINOMECTIN 0.4 %; PRAZIQUANTEL 8.3 % |
|---|---|
| Dosage form | Solution |
| Route | Topical |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 05-Jan-2022 |
| Current status date | 05-Jan-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
Boehringer Ingelheim (Canada) Ltd Ltee — licence 100187, currently licensed, last inspection rating C (2025-03-03).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 25054 | 2021-01-22 | New Drug Submission (NDS) |